Validierungsstudie
Construction and validation of a survival prognostic model for clear cell renal cell carcinoma
Clinical Nephrology · 2025
DOI: 10.5414/cn111509 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Clinical Nephrology, 2025. Verfasst von Chen-Li Li und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Biomarkers, Tumor.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Carcinoma, Renal CellKidney NeoplasmsBiomarkers, TumorHumansMaleFemalePrognosisMiddle AgedAgedKaplan-Meier EstimateGene Expression ProfilingReproducibility of ResultsProportional Hazards ModelsTranscriptomeGene Expression Regulation, NeoplasticNeoplasm GradingNeoplasm Staging
Substanzen
Biomarkers, Tumor
Zitieren
APA
Li, C. L., Jiang, Y. Q., Pan, W., & Yang, Y. L. (2025). Construction and validation of a survival prognostic model for clear cell renal cell carcinoma. Clinical Nephrology. https://doi.org/10.5414/cn111509
Vancouver
Li CL, Jiang YQ, Pan W, Yang YL. Construction and validation of a survival prognostic model for clear cell renal cell carcinoma. Clinical Nephrology. 2025. doi:10.5414/cn111509
BibTeX
@article{Li2025,
author = {Li, Chen-Li and Jiang, Yu-Qian and Pan, Wei and Yang, Yan-Li},
title = {Construction and validation of a survival prognostic model for clear cell renal cell carcinoma},
journal = {Clinical Nephrology},
year = {2025},
doi = {10.5414/cn111509}
}
EUVIMED